Island Sweet Skunk, also known as ISS or Sweet Island Skunk, has been cultivated on Vancouver Island in British Columbia, Canada, for decades. Nirvana's version of this strain made the High Times Top 10 Canadian Strains of All Time list in 2013.
First bred by Federation Seeds, this hybrid should not be confused with Sweet Skunk from Spice of Life. This strain is heavily influenced by Skunk #1 as well as a 1970's California Skunk called Sweet Skunk. A Vietnam veteran brought Sweet Skunk to Federation Seeds, where it was crossed with an unknown Sativa. Smelling and tasting like sweet citrus with a bit of skunk, Island Sweet Skunk is a strain that starts with a perky upbeat high, quickly followed by a soft body buzz.
Description provided by WikiLeaf.
Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
Tilray is a global leader in cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis and hemp company.
A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.
Tilray's experience is unmatched worldwide. Our team of professionals on the ground in 7 countries serves tens of thousands of patients and consumers around the globe. Our GMP-certified cultivation and production facilities are among the most advanced in the world.
We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities to advance the clinical applications of cannabinoids.
Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.